2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 8

In this episode, we review recommendations 51 to 56 from the 2025 American Thyroid Association guidelines on long term management of differentiated thyroid cancer. Key topics include:• The role of ongoing (dynamic) risk stratification in individualized patient management• Decision making for reoperative neck surgery and alternative local therapies such as ethanol and RFA• Indications for additional RAI therapy for cervical lymph node metastases• The role of EBRT in unresectable locoregional recurrences• Radioactive iodine dosing strategies and preparation methods, including dosimetry and TSH stimulation• Management of metastatic disease with RAI, including treatment of pulmonary micrometastases and macronodular metastases